The latest biotech news

News and Trends 23 Nov 2014

Munich: Why is it One of the Best Biotech Cluster in Europe ?

The biotech sector in the Greater Munich area continues to demonstrate significant growth in revenue and staff numbers despite ever-increasing international competition. This continues Munich’s status as one of the pre-eminent locations for this future-oriented industry. This was confirmed by the latest study carried out by the City of Munich, the IHK and BioM based […]

November 23, 2014 - 3 minutesmins - By Julie Lellouche

News and Trends 22 Nov 2014

After AstraZeneca Turned Down Pfizer’s Bid, Merck Took the Opportunity

Pharmaceutical giants Merck and Pfizer have agreed a deal to develop and market immunotherapy agents to fight cancer. Now, the last Pfizer’s proposal to AstraZeneca is pending. Merck will get an upfront payment of €682 million from the U.S. drugmaker for sharing rights to develop its experimental immunotherapy drug with Pfizer. It is also eligible […]

November 22, 2014 - 2 minutesmins - By Julie Lellouche

Deinocossus Synthetic biology france leading

News and Trends 18 Nov 2014

Is France Leading the European Synthetic Biology-Based Biofuel Field?

France has great Synthetic Biology Biotech companies. Paris-based Global Bioenergies carried out the first isobutene production trial in its industrial pilot of Pomacle-Bazancourt in the east of France. Two other companies, Deinove and Fermentalg are growing extremely fast, and giant Total is investing massively in the field. Is France on the good way to become […]

November 18, 2014 - 3 minutesmins - By Julie Lellouche

Intarcia Platform Technology deal Servier

News and Trends 15 Nov 2014

Why do Servier bets one Billion euros on Revolutionary Diabetes Drugs Delivery Device?

The French company Servier wants to invest one billion euros by a partnering with the American company Intarcia regarding their subcutaneous implant for diabetes. This is a breakthrough micropump, the first device without injection able to deliver the molecule Exenatide during one year. It is a huge step forward in treating type 2 diabetes. Indeed, most people forget […]

November 15, 2014 - 2 minutesmins - By Julie Lellouche

News and Trends 14 Nov 2014

Onxeo confirms receipt of the $25M milestone payment from its US partner Spectrum

Onxeo, an innovative company specializing in the development of orphan oncology drugs, founded after the merger of BioAlliance Pharma and Topotarget, announces that it has received from his US partner Spectrum Pharmaceuticals the milestone payment of $25 million related to the approval of Beleodaq by the FDA. Early July 2014, Beleodaq was granted by the […]

November 14, 2014 - 3 minutesmins - By Joachim Eeckhout

News and Trends 14 Nov 2014

A Way to Control Genes within Human Brain?

Researchers at the Department of Biosystems in Basel have developed a novel gene regulation method that enables thought-specific brainwaves to control the conversion of genes into proteins, so the genes expression. It opens new ways to control gene expression within your brain and could lead to brain surgeries. In this new study, bioengineers placed implants inside […]

November 14, 2014 - 2 minutesmins - By Julie Lellouche

News and Trends 13 Nov 2014

BIO-Europe, “The place to be for partnering in Europe”

The title may seem a bit catchy, but that’s what lot of companies told me during my visit at BIO-Europe 2014 in Francfort. Why is it so? Surely because of the high profile of attendees, attracted by the prestigious brand and the leadership of BIO’s events. To open the cession, Anna Chrisman, Group managing Director of […]

November 13, 2014 - 3 minutesmins - By Joachim Eeckhout

News and Trends 11 Nov 2014

Ziarco Pharma raises €27M two years after founding

Ziarco Group Ltd, a British biopharmaceutical start-up focusing on inflammatory skin diseases, bags €27M for Series B financing round. This fast-growing 2 year old company already raised €21.4M in a Serie A lead by Pfizer and is now accelerating even more. This second fundraising will enable clinical Phase II Proof-of-Concept studies for ZPL-389, a histamine H4 receptor antagonist […]

November 11, 2014 - 2 minutesmins - By Julie Lellouche

News and Trends 8 Nov 2014

First Anti-bacterial Enzyme Against MRSA for Use in Humans

Change the way we fight against bacterial infections: MICREOS launches its first anti-bacterial enzyme for use in humans against MRSA (Methicillin-resistant Staphylococcus aureus). Micreos, a Dutch biotech company, has developed Staphefekt™, a bacteria-killing enzyme specific to Staphylococcus aureus, which is equally effective in killing methicillin-resistant Staphylococcus aureus (MRSA) as methicillin-susceptible Staphylococcus aureus (MSSA). Emergence of […]

November 8, 2014 - 3 minutesmins - By Cédric Brock

News and Trends 6 Nov 2014

The First Patient Receives an Implant Pump System to manage Pleural Effusions

For the first time, a pleurapump system designed to manage chronic pleural effusions was implanted in a patient in Marseille (France). This is an innovative device from Sequana Medical AG, a private Swiss medical device company. Chronic pleural effusions is recurrence of excess fluid which collects around the lungs. The most common causes of it are congestive heart […]

November 6, 2014 - 2 minutesmins - By Julie Lellouche

News and Trends 4 Nov 2014

Novo Nordisk invests €104M in new laboratory for Diabetes

Danish insulin giant Novo Nordisk has made a 104 million euros investment in new laboratories at the company’s research and development campus. Based in Malov in Denmark, the lab is expected to be ready for occupation in early 2016. The new facility, Diabetes Research House, will accommodate approximately 350 employees. During the construction phase, the project […]

November 4, 2014 - 1 minutemin - By Julie Lellouche

News and Trends 1 Nov 2014

Apply to OneStart to win €125k for your life sciences/health care business idea

OneStart, organized by Oxbridge Biotech Roundtable and SR One, GSK’s corporate venture capital arm, is today the world’s largest life science/healthcare startup accelerator. Apply by December 1st, 2014 for the chance to win £100k (€125k) as well as free lab space. Do you have an idea, an entrepreneurial opportunity or have you already started? Discover why you […]

November 1, 2014 - 2 minutesmins - By Philip Hemme

Knowledge hub

Categories

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Approaches

Therapeutic areas

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

News and Trends

Munich: Why is it One of the Best Biotech Cluster in Europe ?

After AstraZeneca Turned Down Pfizer’s Bid, Merck Took the Opportunity

Is France Leading the European Synthetic Biology-Based Biofuel Field?

Why do Servier bets one Billion euros on Revolutionary Diabetes Drugs Delivery Device?

Onxeo confirms receipt of the $25M milestone payment from its US partner Spectrum

A Way to Control Genes within Human Brain?

BIO-Europe, “The place to be for partnering in Europe”

Ziarco Pharma raises €27M two years after founding

First Anti-bacterial Enzyme Against MRSA for Use in Humans

The First Patient Receives an Implant Pump System to manage Pleural Effusions

Novo Nordisk invests €104M in new laboratory for Diabetes

Apply to OneStart to win €125k for your life sciences/health care business idea

Subscribe to our newsletter to get the latest biotech news!

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!